reference/18340236

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18340236

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	1545-5017 1545-5009
issueIdentifier	2
pageRange	e29441-
publicationName	Pediatric Blood & Cancer
startingPage	e29441
bibliographicCitation	Aubert L, Petit A, Bertrand Y, Ray-Lunven AF, Angoso M, Pluchart C, Millot F, Saultier P, Cheikh N, Pellier I, Plantaz D, Sirvent A, Thouvenin-Doublet S, Valduga J, Plat G, Rialland F, Henry C, Esvan M, Gandemer V. Therapeutic approach and outcome of children with Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors: An SFCE retrospective study. Pediatr Blood Cancer. 2022 Feb;69(2):e29441. doi: 10.1002/pbc.29441. PMID: 34854546.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ec54e4a9e073f768ab067400e6790fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9cc2b939ba0c11d7c88a9ae2b17b883f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3095-568X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8246e35f883b723094400cf1c7a93c72 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1bf333648d1c4347904a4dd311984ecd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_639e6c49f903422236dd607e94089b82 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6327-0898 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97740210d9be85208ecba57b14af870d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8457-4487 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5e62ebbd9c0b244c7fe5d75c9800af5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5237b8e11338d429de519cb61c1c9df0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4991-233X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4555347cbb620e59ee9c7dde37c9707d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d462b74349422f25da1283ca76b5588 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af8e51ee0948f70459f2b38c1f76b3d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9997a222c2a0fb27085a4c6745a97a57 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dca086b86347b4ca79fc2ed10c696a87 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_032b5735a0f520b95f75fba2352b7ac3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98eb573ac3b219437f87f6b12f4b5044 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a84b97da81fcd889443cea35fdd0c6f
date	2021-12-02^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/34854546 https://doi.org/10.1002/pbc.29441
isPartOf	https://portal.issn.org/resource/ISSN/1545-5009 https://portal.issn.org/resource/ISSN/1545-5017 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30479
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Therapeutic approach and outcome of children with Philadelphia chromosome‐positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors: An SFCE retrospective study
discusses	http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0024527
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D054198Q000235 http://id.nlm.nih.gov/mesh/D054198Q000188 http://id.nlm.nih.gov/mesh/D018380Q000009
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D002648 http://id.nlm.nih.gov/mesh/D012008 http://id.nlm.nih.gov/mesh/D010677 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D016044Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8870 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11043 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168069230

Showing number of triples: 1 to 55 of 55.